BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 12904090)

  • 1. Insulin glargine: an updated review of its use in the management of diabetes mellitus.
    Dunn CJ; Plosker GL; Keating GM; McKeage K; Scott LJ
    Drugs; 2003; 63(16):1743-78. PubMed ID: 12904090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin glargine: a review of its therapeutic use as a long-acting agent for the management of type 1 and 2 diabetes mellitus.
    McKeage K; Goa KL
    Drugs; 2001; 61(11):1599-624. PubMed ID: 11577797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin glargine: a systematic review of a long-acting insulin analogue.
    Wang F; Carabino JM; Vergara CM
    Clin Ther; 2003 Jun; 25(6):1541-77, discussion 1539-40. PubMed ID: 12860485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spotlight on insulin glargine in type 1 and 2 diabetes mellitus.
    McKeage K; Goa KL
    Treat Endocrinol; 2002; 1(1):55-8. PubMed ID: 15765621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medication of the month. Insulin glargine (Lantus)].
    Scheen AJ
    Rev Med Liege; 2004 Feb; 59(2):110-4. PubMed ID: 15112902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine.
    Warren E; Weatherley-Jones E; Chilcott J; Beverley C
    Health Technol Assess; 2004 Nov; 8(45):iii, 1-57. PubMed ID: 15525480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin glargine (Lantus).
    Owens DR; Griffiths S
    Int J Clin Pract; 2002; 56(6):460-6. PubMed ID: 12166545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin glargine.
    Campbell RK; White JR; Levien T; Baker D
    Clin Ther; 2001 Dec; 23(12):1938-57; discussion 1923. PubMed ID: 11813930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin glargine: a new basal insulin.
    Levien TL; Baker DE; White JR; Campbell RK
    Ann Pharmacother; 2002 Jun; 36(6):1019-27. PubMed ID: 12022906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin aspart: a review of its use in the management of type 1 or 2 diabetes mellitus.
    Reynolds NA; Wagstaff AJ
    Drugs; 2004; 64(17):1957-74. PubMed ID: 15329046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.
    Rosenstock J; Park G; Zimmerman J;
    Diabetes Care; 2000 Aug; 23(8):1137-42. PubMed ID: 10937511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus.
    Chapman TM; Noble S; Goa KL
    Drugs; 2002; 62(13):1945-81. PubMed ID: 12215068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes.
    Home PD; Rosskamp R; Forjanic-Klapproth J; Dressler A;
    Diabetes Metab Res Rev; 2005; 21(6):545-53. PubMed ID: 16021649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin glargine: the first clinically useful extended-action insulin analogue.
    Ashwell SG; Home PD
    Expert Opin Pharmacother; 2001 Nov; 2(11):1891-902. PubMed ID: 11825324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycaemic control in type 2 diabetes mellitus patients undergoing major surgery: comparison of three subcutaneous insulin regimens.
    Mathur SK; Bansal A; Khan ZY
    J Indian Med Assoc; 2009 Nov; 107(11):759-61. PubMed ID: 20469779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin detemir: a review of its use in the management of diabetes mellitus.
    Keating GM
    Drugs; 2012 Dec; 72(17):2255-87. PubMed ID: 23110609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin glargine: a new long-acting insulin product.
    Reinhart L; Panning CA
    Am J Health Syst Pharm; 2002 Apr; 59(7):643-9. PubMed ID: 11944604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin glargine: a new once-daily basal insulin for the management of type 1 and type 2 diabetes mellitus.
    Lam S
    Heart Dis; 2003; 5(3):231-40. PubMed ID: 12783637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
    Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
    Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin glargine.
    Gillies PS; Figgitt DP; Lamb HM
    Drugs; 2000 Feb; 59(2):253-60; discussion 261-2. PubMed ID: 10730548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.